-
-
-
ICICI Securities recommended reduce rating on Cohance Lifesciences with a target price of Rs 640 in its research report dated November 13, 2025.
-
Stocks to Watch, 13 November: Stocks like Tata Steel, Lloyds Metals and Energy, Prestige Estates Projects, Nazara Technologies, Indian Railway Catering and Tourism Corporation IRCTC, Entero Healthcare Solutions, Endurance Technologies, Ircon International, Cohance Lifesciences, and Data Patterns will be in focus on November 13.
-
Stocks to Watch, 29 October: Stocks like Shree Cement, Jindal Steel, Tata Capital, Mahindra and Mahindra Financial Services, Premier Energies, DCM Shriram, Ideaforge Technology, Happiest Minds Technologies, Novartis India, Sundram Fasteners, CreditAccess Grameen, and Star Health and Allied Insurance Company will be in focus on October 29.
-
Stocks to Watch, 19 September: Stocks like Unichem Laboratories, LT Elevator, One Mobikwik Systems, Vedanta, John Cockerill India, Texmaco Rail and Engineering, JSW Energy, Sasken Technologies, and Waaree Energies will be in focus on September 19.
-
US-based Advent International, through its arm Jusmiral Holdings, which is also the promoter of Cohance Lifesciences, offloaded 3,41,48,000 shares representing an 8.92 per cent stake in the company
-
Cohance Lifesciences shares corrected 5.55 percent to close at Rs 912.7 on the NSE after gap-down opening.
-
While Jusmiral Holdings is reported to be the seller, Jefferies remains bullish on the CRDMO story, assigning a Buy rating and Rs 1,150 target price
-
Stocks to Watch, 18 September: Stocks like Cochin Shipyard, Dixon Technologies, Cohance Lifesciences, Indosolar, Biocon Gujarat Fluorochemicals, Airfloa Rail Technology, BR Goyal Infrastructure, Aavas Financiers, Federal Bank, Yes Bank, and Bandhan Bank will be in focus on September 18.
-
Stocks to Watch, 12 September: Stocks like Infosys, Canara Bank, Lodha Developers, Bharat Forge, Consolidated Construction Consortium, NBCC, JBM Auto, Marico, GMR Power, Travel Food Services, RailTel Corporation of India, and Prostarm Info Systems will be in focus on September 12.
-
Net Sales are expected to decrease by 34.3 percent Y-o-Y (up 13.2 percent Q-o-Q) to Rs 552.4 crore, according to ICICI Securities.
-
-
ICICI Securities is bullish on Cohance Lifesciences recommended buy rating on the stock with a target price of Rs 1365 in its research report dated May 29, 2025.
-
Stocks to watch, 29 May: Stocks like Bharat Rasayan, HeidelbergCement India, Birlasoft,Som Distilleries and Breweries, Natco Pharma, Deepak Nitrite, RITES, Aurobindo Pharma, IndusInd Bank, Steel Authority of India, Avanti Feeds, Insecticides India, Balaji Amines, Cummins India, ITC, ADF Foods, Mishra Dhatu Nigam, and Unified Data Tech Solutions will be in focus on May 29.
-
In September 2023, the US-based private equity firm Advent acquired a controlling stake in Suven, expressing the intent to create a billion-dollar platform in the CDMO space.
-
The current vendor diversification drive by big pharma is driving large business opportunities for Indian CDMOs
-
Suven Pharmaceuticals Limited on February 29 announced a scheme of amalgamation for merger with Cohance Lifesciences Limited
-
The overall transaction is expected to conclude over the next 12-15 months subject to receipt of all relevant shareholder and regulatory approvals.
-
TPG Capital picked up a stake in Manipal Hospitals for Rs 900 crore in February 2015 and has been looking to clock returns on its 7 year old bet. India’s sovereign wealth fund NIIF is the other external investor in the Ranjan Pai-led hospital chain
